This volume is unique in reporting on strategies for the application of
molecular targeted imaging agents such as antibodies, peptides, receptors and
contrast agents in the biologic grading of tumors, differential diagnosis of
tumors, prediction of therapeutic response and monitoring tumor response to
treatment. It also includes updated information on the imaging of tumor
angiogenesis, hypoxia, apoptosis and gene delivery as well as expression in the
understanding and utility of tumor molecular biology for better cancer
management.